Differences

This shows you the differences between two versions of the page.

--- publications [2020/01/10 10:04]
ramirez [2018]
+++ publications [2020/01/21 10:38]
ramirez [2020]
@@ Line 2: / Line 2: @@
 ===== 2020  =====
-Hänscheid T, Grobusch MP. 2020. <fc #0000FF>Coenzyme Q10 and cerebral malaria in mice: Questionable interpretations, improbable usefulness in humans</fc>. Parasitol Int 74:101969. [[http://www.ncbi.nlm.nih.gov/pubmed/31421269|(PMID: 31421269)]]
+van der Linden M, Mamede R, Levina N, Helwig P, Vila-Cerqueira P, Carriço JA, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], [[people:emartins|Martins ER]]. 2019. <fc #0000FF>Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany</fc>. J Antimicrob Chemother. 75:296–299. [[http://www.ncbi.nlm.nih.gov/pubmed/31740946|(PMID: 31740946)]]
+Hänscheid T, Grobusch MP. 2020. <fc #0000FF>Coenzyme Q10 and cerebral malaria in mice: Questionable interpretations, improbable usefulness in humans</fc>. Parasitol Int 74:101969. [[http://www.ncbi.nlm.nih.gov/pubmed/31421269|(PMID: 31421269)]]
 ===== 2019  =====
 [[people:afriaes|Friães A]], [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], Portuguese Group for the Study of Streptococcal Infections. 2019. <fc #0000FF>Changes in //emm// types and superantigen gene content of //Streptococcus pyogenes// causing invasive infections in Portugal</fc>. Sci Rep 9:18051. [[http://www.ncbi.nlm.nih.gov/pubmed/31792274|(PMID: 31792274)]]
 Hänscheid T, Schlagenhauf P, Grobusch MP. 2019. Atovaquone/proguanil for malaria chemoprophylaxis - Could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure? Travel Med Infect Dis 101527. [[http://www.ncbi.nlm.nih.gov/pubmed/31759143|(PMID: 31759143)]]
-van der Linden M, Mamede R, Levina N, Helwig P, Vila-Cerqueira P, Carriço JA, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], [[people:emartins|Martins ER]]. 2019. <fc #0000FF>Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany</fc>. J Antimicrob Chemother. //In press//. [[http://www.ncbi.nlm.nih.gov/pubmed/31740946|(PMID: 31740946)]]
 Duque-Valencia J, Forero-Muñoz NR, Díaz FJ, [[people:emartins|Martins E]], Barato P, Ruiz-Saenz J. 2019. <fc #0000FF>Phylogenetic evidence of the intercontinental circulation of a canine distemper virus lineage in the Americas</fc>. Sci Rep 9:15747. [[http://www.ncbi.nlm.nih.gov/pubmed/31673120|(PMID: 31673120)]]
@@ Line 37: / Line 36: @@
 Björnsdóttir ES, [[people:emartins|Martins ER]], Erlendsdóttir H, Haraldsson G, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], Kristinsson KG. 2019. <fc #0000FF>Group B streptococcal neonatal and early infancy infections in Iceland 1976 - 2015</fc>. Pediatr Infect Dis J. 38:620–624. [[http://www.ncbi.nlm.nih.gov/pubmed/30299423|(PMID: 30299423)]]
-Huizenga E, van der Ende J, Zwinkels N, Jimissa A, van der Ende-Bouwman C, van Rooijen R, Kargbo B, Agnandji ST, Hänscheid T, Goorhuis A, Grobusch MP. 2018. <fc #0000FF>A modified case definition to facilitate essential hospital care during Ebola outbreaks</fc>. Clin Infect Dis. 68:1763–1768. [[http://www.ncbi.nlm.nih.gov/pubmed/30239602|(PMID: 30239602)]]
+Huizenga E, van der Ende J, Zwinkels N, Jimissa A, van der Ende-Bouwman C, van Rooijen R, Kargbo B, Agnandji ST, Hänscheid T, Goorhuis A, Grobusch MP. 2019. <fc #0000FF>A modified case definition to facilitate essential hospital care during Ebola outbreaks</fc>. Clin Infect Dis. 68:1763–1768. [[http://www.ncbi.nlm.nih.gov/pubmed/30239602|(PMID: 30239602)]]
+Hänscheid T, Grobusch MP. 2019. <fc #0000FF>Could antibiotic treatment of traveller’s diarrhoea even prolong elimination of pathogens?</fc> Travel Med Infect Dis. 28:104. [[http://www.ncbi.nlm.nih.gov/pubmed/30030070|(PMID: 30030070)]]
 ===== 2018  =====
 Caneiras C, Calisto F, Jorge da Silva G, Lito L, [[people:jmelocristino|Melo-Cristino J]], Duarte A. 2018. <fc #0000FF>First description of colistin and tigecycline-resistant //Acinetobacter baumannii// producing KPC-3 carbapenemase in Portugal</fc>. Antibiotics 7. [[https://doi.org/10.3390/antibiotics7040096|doi:10.3390/antibiotics7040096]] [[http://www.ncbi.nlm.nih.gov/pubmed/30404152|(PMID: 30404152)]]